HIGHLIGHTS
- who: Josef Vymazal and collaborators from the Medical University of Vienna, Austria have published the paper: Eighteen yearsu2019 experience with tumor treating fields in the treatment of newly diagnosed glioblastoma, in the Journal: (JOURNAL) of June/15,/2022
- what: The aim of this study was to describe outcomes of TTFields therapy for a consecutive cohort of newly-diagnosed glioblastoma patients treated both within the clinical trial as well as routine clinical practice settings over a period of 18 years. The study demonstrates the positive effect of TTFields on both PFS and OS in patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.